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Regardless of the different diagnosis methods than can
exist,1–3 medical diagnosis is a practice based on diverse
approaches that aim to ﬁnd out the causes of a pathology
or the underlying reasons of an unhealthy status. A robust
diagnosis needs to lie on a variety of approaches that com-
bine elements including questionnaire, imagery and analysis.
The biomedical analyses may be the most commonly used
approaches in the medical diagnosis, especially for the molec-
ular diagnosis,4–6 due to the variety of parameters they cover
and the different abnormalities they can reveal.
Biomedical analyses have challenges to overcome, yet stan-
dards to respect. Indeed, it is important to select the appropri-
ate biological sample, the time of sampling and the condition
under which it is sampled in terms of period, patients’ diet,
patient’s age and the drugs the patients are taking. For
instance, to test blood sugar or blood lipids the patients should
fast several hours before the blood is drawn, in addition, when
interpreting the results the clinician should take into consider-
ation the fact that a patient is taking some drugs like insulin,
anti-cholesterol drugs, other medicines or even some types of
food or natural products7 that interact with the metabolic pro-
cess which may inﬂuence the level of some biological molecules
such as glucose, triglycerides and cholesterol.
Furthermore, based on what we are looking for or what we
are suspecting, choosing the type of sample and the region to
sample represents an important issue. In fact, some false diag-
noses can be due to a wrong sampling choice such as searching
for a speciﬁc antibody in the blood of an immune-deﬁcient
patient who will have a limited amount of antibodies instead
of searching for other disease markers. This may happen when
the pathological status of the patient is not well reported.
Another example of a sampling choice in terms of time and
region is diagnosing infections where different options may
exist including antibody detection, bacterial or inﬂammatory
marker detections and depending on the infection phases and
the patients we may base our diagnosis on one or more of
those parameters.The laboratory steps of the medical analysis also represent
an important issue. Indeed, the equipment quality and the
appropriate use of it, in addition to the selection of the analyt-
ical methods along with the use of suitable reagents at the opti-
mum conditions especially those able to react with the live cells
are important.8 These factors can inﬂuence the results based on
which a doctor will prescribe a drug, adjust the dosage of treat-
ment, ask for further analysis or recommend a diet for the
patient. Thus, the experimental steps of the laboratory should
be given more importance and the laboratory personnel need
to receive appropriate training. Furthermore, the patients need
to be educated regarding the precautions related to the bio-
medical analysis and need to respect the diet recommended
by doctors or clinicians, be punctual for the sampling and
report any details that may inﬂuence the results such as the dis-
ease familial history and an eventual treatment that the patient
is taking.
These concepts can also be recommended for similar
biological approaches used in scientiﬁc research in areas such
as pharmacology, genetics and immunology to reach new
advances toward new drug development9,10 for medical usage.
However, in diverse cases the biomedical analysis is not
enough for a precise diagnosis and further complementary
tests and explorations such as imageries, physiological tests
and exploratory surgery are required to map the pathological
status of patients. In all cases, the collaboration of all the
individuals concerned, starting form clinicians, laboratory
assistants, pharmacists and the family members of the patients;
is the minimum requirement to optimize the results and the
efﬁciency of the biomedical analysis toward an accurate
diagnosis.Conﬂict of interest
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